Self-harm and the Prison Environment Mixed Methods Study
Launched by KING'S COLLEGE LONDON · Mar 25, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the environment inside prisons can affect self-harming behavior among both men and women. Self-harm is a significant issue in UK prisons, and understanding the factors related to the prison setting—like living arrangements, daily activities, and interactions with staff and other prisoners—can help improve care and support for those at risk. By interviewing and observing a group of prisoners over 12 weeks, researchers hope to identify which specific aspects of the prison environment are linked to self-harm. They will also gather opinions from prisoners and staff to better understand these findings.
If you're a new prisoner and meet certain criteria, you may be eligible to participate in this study. To take part, you must be entering prison for the first time and able to give informed consent. Participants can expect to complete some assessments and share their experiences in focus groups or interviews. This research aims to create better strategies that could ultimately reduce self-harm incidents in prisons, making the environment safer for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - New entrants to prison
- Exclusion Criteria:
- • Expected release/transfer date less than 12 weeks from date of entry
- • Lack capacity to give informed consent
- • Insufficient spoken English skills to participate
- • Assessed persistently as not safe to be seen face to face due to imminent high risk of violence.
- • Risk of psychological harm from participation more than minimal (based on risk assessment with prison's Safer Custody and mental health teams)
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported